Clinical Trials Directory

Trials / Unknown

UnknownNCT03385434

Evaluation of Endorings-2-assisted Colonoscopy: a New Accessory for Improvement of Adenoma Detection Rate?

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
292 (estimated)
Sponsor
University Hospital Muenster · Academic / Other
Sex
All
Age
18 Years – 99 Years
Healthy volunteers
Accepted

Summary

Screening colonoscopy for colorectal cancer is essential to diagnose and remove adenomas, precancerous stages of colorectal cancer. Unfortunately approximately 25 % of all adenomas are missed during the examination. Recently a new colonoscopy accessory, the Endorings-2 (EndoAid Ltd., Casearea, Israel), has been designed to improved the detection of adenomas during colonoscopy (adenoma detection rate). Endorings-2 is a silicone-rubber device that is fitted on the colonoscope and is equipped with circular flexible silicon rings mechanically stretching the colonic folds during withdrawal. This study aims to evaluate the efficacy of Endorings-2 to improve the adenoma detection rate in a prospective, blinded clinical trial. 292 patients with an indication for a screening colonoscopy shall be included (1:1 randomization in standard colonoscopy versus Endorings-2-assisted colonoscopy).

Conditions

Interventions

TypeNameDescription
DEVICEEndorings-2292 patients with an indication for screening colonoscopy will be included. 146 patients will receive a standard colonoscopy and 146 patients will receive an Endorings-2 assisted colonoscopy (1:1 standard colonoscopy vs Endorings-2-assisted colonoscopy).

Timeline

Start date
2018-02-01
Primary completion
2021-08-30
Completion
2022-02-01
First posted
2017-12-28
Last updated
2020-06-16

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT03385434. Inclusion in this directory is not an endorsement.